The ADMIT series--issues in inhalation therapy. 3) Mild persistent asthma: the case for inhaled corticosteroid therapy

ADMIT Working Group, Chris J Corrigan, Mark L Levy, Pn Richard Dekhuijzen, Graham K Crompton

Research output: Contribution to journalArticlepeer-review

Abstract

Mild persistent asthma should be treated with continuous inhaled corticosteroids (ICS), which reduces exacerbations of disease, controls symptoms and reduces bronchial mucosal inflammation. Most patients can be controlled with low dosage ICS (
Original languageEnglish
Pages (from-to)148-58
Number of pages11
JournalPrimary Care Respiratory Journal
Volume18
Issue number3
DOIs
Publication statusPublished - 2009

Fingerprint

Dive into the research topics of 'The ADMIT series--issues in inhalation therapy. 3) Mild persistent asthma: the case for inhaled corticosteroid therapy'. Together they form a unique fingerprint.

Cite this